Diuretic Therapy in Severe Renal Insufficiency

Introduction to Diuretic Therapy

For patients with a creatinine clearance <30 ml/min, loop diuretics are preferred over thiazide diuretics, as the latter are ineffective in this population, according to the European Society of Cardiology 1, 2
In patients with significant renal dysfunction (creatinine >221 μmol/L or eGFR <30 ml/min/1.73 m²), the effectiveness of diuretics may be impaired or worsen renal function, as stated by the European Society of Cardiology 3, 4

In patients with heart failure and renal insufficiency, a more intensive diuretic therapy is often required to remove excess salt and water, as recommended by the European Heart Journal 2
The combination of different diuretics (e.g., loop diuretics plus thiazides) increases the risk of hypovolemia, hypotension, hypokalemia, and worsening renal function, according to the European Journal of Heart Failure 3, 4

Loop diuretics are the preferred diuretics in severe renal insufficiency, as stated by the European Society of Cardiology 1, 2
The dose should be adjusted according to symptoms and signs of congestion, blood pressure, and renal function, as recommended by the European Journal of Heart Failure 3, 4
In cases of diuretic resistance, various strategies can be applied, including sodium restriction, intravenous administration of loop diuretics, or combination with dopamine, as suggested by the European Heart Journal 5

Regular monitoring of renal function and electrolytes (every 1-2 weeks after initiation and after each dose increase) is necessary, as recommended by the European Journal of Heart Failure 3, 4
Monitoring of urea/BUN, creatinine, and potassium is essential, as stated by the European Journal of Heart Failure 3, 4
Caution should be exercised when using ACE inhibitors, ARBs, or renin inhibitors concomitantly, due to the risk of hypotension, as recommended by the European Journal of Heart Failure 3, 4
NSAIDs should be avoided, as they can weaken the effect of diuretics and impair renal function, according to the European Journal of Heart Failure 3, 4